| dc.contributor.author | Kirby, Michael | |
| dc.contributor.author | Thor, K.B. | |
| dc.date.accessioned | 2011-10-11T12:01:05Z | |
| dc.date.available | 2011-10-11T12:01:05Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Kirby , M & Thor , K B 2008 , ' Is duloxetine safe and effective for the treatment of overactive bladder? ' , Nature Reviews Urology , vol. 5 , no. 4 , pp. 188-189 . https://doi.org/10.1038/ncpuro1077 | |
| dc.identifier.issn | 1759-4812 | |
| dc.identifier.other | PURE: 408501 | |
| dc.identifier.other | PURE UUID: 193bbe87-f61a-437f-ab36-c6127d7b2f49 | |
| dc.identifier.other | Scopus: 42049107833 | |
| dc.identifier.uri | http://hdl.handle.net/2299/6643 | |
| dc.description | Original article can be found at: http://www.nature.com/ Copyright Nature Publishing Group [Full text of this article is not available in the UHRA] | |
| dc.description.abstract | Overactive bladder (OAB) is frequently treated with antimuscarinic agents; however, the serotonin-noradrenaline reuptake inhibitor (SNRI) duloxetine has demonstrated efficacy in animal models of OAB, and might be effective in humans. | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Nature Reviews Urology | |
| dc.title | Is duloxetine safe and effective for the treatment of overactive bladder? | en |
| dc.contributor.institution | Centre for Postgraduate Medicine | |
| dc.contributor.institution | Health & Human Sciences Research Institute | |
| dc.description.status | Peer reviewed | |
| rioxxterms.versionofrecord | https://doi.org/10.1038/ncpuro1077 | |
| rioxxterms.type | Journal Article/Review | |
| herts.preservation.rarelyaccessed | true | |
